Bill > S3797

This bill, titled the "Prohibiting Tianeptine and Other Dangerous Products Act of 2026," aims to strengthen regulations on dietary supplements by amending the Federal Food, Drug, and Cosmetic Act, which is the primary law governing food and drugs in the United States. Specifically, it introduces new prohibited acts, meaning actions that are against the law, related to dietary supplements. The bill makes it illegal to introduce or sell products marketed as dietary supplements into interstate commerce if they do not actually meet the legal definition of a dietary supplement, which is a product intended to supplement the diet and contains one or more dietary ingredients. Furthermore, it prohibits the introduction or sale of dietary supplements that were prepared, packed, or held with the help of or at the direction of someone who has been debarred, meaning they are prohibited from participating in certain activities related to regulated products. These new prohibitions are integrated into existing legal frameworks, allowing for the exclusion of such products from import and providing authorities for their seizure if they are found to be in violation of these new rules.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/3797/all-info